This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Under existing regulations, the agency only licenses one facility — the University of Mississippi — to cultivate cannabis for use in FDA-approved clinical trials. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received.
A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators. “[This filing is] asking the court for an order compelling the DEA to process our application.
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 It was the second-lowest number of arrests reported by the DEA in the past decade.
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
In a Notice of Proposed Rulemaking , published this week in the Federal Register , the agency acknowledges its longstanding failure to act upon the 35 bulk cultivation applications before it. The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants.
million cultivated marijuana plants in 2022. The post DEA Reports More Marijuana Seizures, Fewer Arrests in 2022 appeared first on NORML. Federal law enforcement agents and their partners seized nearly 5.7 This is the highest annual seizure total reported by the agency since 2011.
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.
SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to facilitate the cultivation of … Read More. The post Document – DEA: Controls To Enhance the Cultivation of Marihuana for Research in the United States first appeared on Cannabis Law Report. ACTION: Final rule.
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.
With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?
Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production. million grams, according to reporting by Marijuana Moment.
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .”
Cultivation Costs for Homegrowers. Indoor cannabis cultivation allows an average of four harvests each year instead of one. However, indoor cultivation is generally more expensive. Those three million home growers are expected to cultivate approximately 11 million pounds of dried cannabis in 2022.
The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.
After years of delays, legal challenges, and obfuscation, the US Drug Enforcement Agency (DEA) finally announced that it would begin evaluating applications for federally-licensed research cannabis cultivators. . In 2019, a federal judge forced the DEA to explain its inaction.
as a federally licensed cannabis cultivator and product manufacturer. Including Bright Green, eight entities are now registered with the DEA as federally licensed cannabis “bulk manufacturers.” Drug Enforcement Administration has officially registered publicly traded Bright Green Corp. 31, 2022 – has announced plans […]
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. Watch out for penny stock predators and CBD snake oil cultivators and unsavoury extractors.
The Therapeutic Potential of Cannabis is Profound – What Many Cultivators Grow However is Not. Another company that will be cultivating cannabis for research is a pharmaceutical research company. The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central.
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .
USDA Ditches DEA Registration. Drotleff also covered a very promising statement from USDA Undersecretary Greg Ibach, who told the NASDA that the USDA has reached an agreement with the Drug Enforcement Agency (DEA) to remove the requirement that only DEA-registered labs test hemp for THC.
Attorneys representing a cannabis biopharma conglomerate and federal cannabis cultivation license applicant filed a petition in court today, citing that the Drug Enforcement Agency (DEA) is taking too long to issue a determination for its application. . Breaking Exclusive: Another Cannabis Company Sues the DEA. Read more at.
Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.
For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies. The post Senate Passes Bill Authorizing Attorney General to Increase Number of Federally Licensed Cannabis Providers appeared first on NORML.
Since 1968, the University of Mississippi has been the only entity cleared by the Drug Enforcement Administration (DEA) and funded by NIDA to grow cannabis for FDA-approved research. or less THC. ” U.S. .” ” U.S.
Marijuana might be federally prohibited, but the Drug Enforcement Administration (DEA) has effectively acknowledged that the plant’s seeds are generally uncontrolled and legal, regardless of how much THC might end up being produced in buds if those seeds were cultivated. percent THC. percent delta-9 THC. “In
This shipment marks a tremendous milestone in the evolution of the US cannabis industry, as it represents one of the first imports of live Cannabis plants to a federally licensed US cultivator. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources.
Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. But despite all the DEA’s seizing and destroying, it’s clear that the average U.S. That’s what DEA data indicates, at least — especially when looked at closely.
The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. According to the data published in the DEA’s yearly Domestic Cannabis Eradication/Suppression Program Statistical Report, approximately 4.54
Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.
Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.
Under this proposal, the AG is also provided with the ability to authorize increases in the total number of federally approved marijuana cultivators. The Attorney General is provided with a 60-day timeline to either affirm or reject applicants for licensure. BILLS-117s253es. Senate members in 2020 passed a similar version of S.
The Drug Enforcement Administration (DEA) finalized its plans to authorize the cultivation of 3,200,000 grams of marijuana for research purposes next year—a 30 percent increase from 2019’s quota. DEA initially proposed 2020 production quotas in a notice published in the Federal Register in September. tons of cannabis.
State-level marijuana legalization has left the Drug Enforcement Administration (DEA) with far fewer samples of seized illicit cannabis to analyze, a study led by a top marijuana investigator for the federal government says. Authorities in Southern Oregon & the High Plains in California might argue differently !
Hemp growers are unhappy over the DEA’s hemp rule. The Cannabis Legalisation and Control Bill would require the legislature to enact rules for sales, allow adults to buy up to 14 grams of marijuana per day and permit home cultivation of up to four plants per household. dea hemp rule.
Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes. The DEA dragged their feet on this plan for years, so lawsuits were filed. The DEA’s newly-licensed marijuana growers can therefore use tissue cultures and genetic materials to do everything they can do with seeds described above.
Bank of America Closes Account of DEA-Approved Cannabis Researcher. Drug Enforcement Administration (DEA) in May to be a federally authorized cultivator of research-grade cannabis. “Observable signs of use that do not indicate impairment on their own cannot be cited as an articulable symptom of impairment,” the DOL stated.
Accordingly, the USDA held that the DEA “no longer has authority to require hemp seed permits for import purposes.”. According to the Montana senator, the DEA was blocking Montana farmers from importing hemp seeds. The agency further explained that the statement aimed to provide assistance to U.S.
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers.
Only one supplier, the University of Mississippi , has been given the go-ahead to cultivate cannabis for research purposes. . Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research. In late 2020, the new regulations were finalized.
You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8 Across the United States, the DEA seized 2.82 million plants in 2017.
While several lawmakers and industry stakeholders celebrated the announcement , not everyone on the cultivation side is so positive. This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. New Sampling Guidelines. What does this mean for hemp farmers?
Drug Enforcement Administration (“DEA”) published an interim final rule surrounding hemp and hemp derivatives. In fact, most state departments of agriculture allowing for hemp cultivation under the 2014 Farm Bill expressly refused to regulate hemp processing. By: Nabil Rodriguez. Last week on Thursday August 20, 2020, the U.S.
In mid-October, California Governor Gavin Newsom approved a bill ( SB-153 ) that dramatically changed California’s hemp cultivation laws. percent limit, and in effect limits what kinds of hemp breeds that cultivators can use or which harvests can move down the stream of commerce.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content